VanHealthing

VanHealthing

Created using Figma
生物技术创新的VANHEALTHING Cryptofund是一个绝对独特的投资平台:利润与首屈一指的生物技术项目相结合,可以拯救和改善人类生活。
数据不可用
2018年6月1日
2018年8月31日
100% 完成
募集资金 - 无数据
past
令牌详细信息
断续器
HEALTH
公司详情
注册国家
Ukraine
额外细节
KYC
分类
Cryptocurrency, 健康, 人工智能

关于 VanHealthing

VANHEALTHING生物技术创新的Cryptofund是一个独特的投资平台,与目前存在的任何其他投资平台不同。我们结合了尖端的生物技术项目,有效的财务管理和社会责任。这创造了一个由科学团队,研发基础设施和组织能力构成的自我维持生态系统。后者通过使用区块链,软件和更传统的方法来提供支持。
前两种方法在适当的地方使用,而不会在我们的基础设施中产生不必要的依赖。

换句话说,我们的系统包括社会需要创造,发展和实施有效的生物和医疗技术的所有健康(在每个意义上)。我们基金开发的模型的本质是大多数传统机构(无论是商业机构,政府机构还是非营利机构)的功能替代品,也是医疗保健中其他产品或服务的替代品。

VANHEALTHING将众多自给自足的公司和产品合并为一个团队。我们的每个投资组合项目即使被认为是自己的投资也值得投资,但我们的目标是在我们的生态系统中使用技术协同作用并简化通常成为官僚机构或低效规划的受害者的流程。我们的高效率基于我们对项目开发和实施的所有阶段的了解。我们负责所有的管理和支持责任,让科学家们做他们最擅长的事情–拯救和改善生活。因此,我们的基金会为每个人提供更好的生活质量。

VANHEALTHING生物技术创新的Cryptofund运营在一个将塑造未来世界的领域,以及人工智能和替代能源等领域。让我们与众不同的是我们透明的管理方法,人道主义价值观,对最先进创新项目的重视,以及易于获取技术的理念:为投资者提供优质服务,为未来客户提供轻松获取的途径。每一次新的突破都可能意味着成千上万的生命得到改善或挽救社会责任是我们基金的核心价值。

%name%Roadmap

  • September 2014

  • First angel investment into the Force project.
  • June 2015

  • The USP Capital venture fund is launched.
  • September 2015

  • First Successful Kickstarter campaign completed by our portfolio company.
  • November 2015

  • Successful cardio-screening of 22 433 patients in rural areas. The Platform 20k project is born.
  • 阅读更多
  • Devember 2015

  • Plans for the word's first psychometer are formulated - a unique device for constant monitoring of an individual's psycho-emotional state.
  • January 2016

  • The TRL3 experiment for the world's first one-hand ECG sensor is successfully conducted.
  • February 2016

  • Incorporation of Platform 20k and Planexta Inc.
  • April 2016

  • Start of development on PRECISE - the automated ECG interpretation project.
  • September 2016

  • Start of development on the world's first sleeveless arterial blood pressure monitor with +- 5 mg Hg accuracy.
  • November 2016

  • Successful completion of the SenceBand crowdfunding campaign.
  • January 2017

  • SenceBand receives two CES 2017 awards in the biotechnologies and wearable devices categories.
  • March 2017

  • One of our portfolio companies is chosen for the Vertical accelerator (Finland), considered to be one of the world's best accelerators in digital health tech.
  • April 2017

  • One of our portfolio companies is chosen for the Alchemist accelerator (U.S.A.), considered to be one of the world's best accelerator programs. The digital beta of PRECISE is launched.
  • May 2017

  • Start of clinical trials for PRECISE.
  • July 2017

  • The Fund's portfolio increases to 12 companies - a major new milestone.
  • August 2017

  • Start of the Fund's transformation into a cruptocurrency fund.
  • September 2017

  • The Cryptofund's development strategy is finalized. Publication of a fundamental scientific paper on aging predictor analysis and the dynamic estimation of biological age.
  • October 2017

  • The Cryptofund's portfolio is created. The medical version of SenceBand is named among the top 20 remote assistance projects of 2017 by HealthcareTech Outlook.
  • November-December 2018

  • The Fund conducts a Roadshow for the purpose of engaging investors and partners for the Cryptofund.
  • January 2018

  • Establishment and registration of the Cryptofund.
  • February 2018

  • Creation of the Cryptofund's board of directors and investment strategy.
  • February - August 2018

  • Preparation for the ITO and coordination with regulators for the purpose of issuing tokens.
  • March 2018

  • Establishment of the Cryptofund's hedge-fund division for the purpose of liquidity management.
  • August 2018

  • Demonstration of successful technological and financial results by the Cryptofund's portfolio companies.
  • September 2018

  • Launch of our ITO.
  • October 2018

  • Portfolio companies begin invesment using gathered funds.
    Launch of the first stage of our A.R.K. infrastructure project specifically - the initial laboratory construction phase.
  • November 2018

  • Payment of dividens to token owners.
  • November 2018

  • Launch of the final stage of the A.R.K. infrastructure project.
  • January 2019

  • Launch of new technological projects within the Cryptofund.

VanHealthing 球队

验证 50%

注意。未经证实的成员实际上可能不是团队成员

Alexander Lobanov
Chief investment officer
验证
Alexander Tulko
Head of asset management
验证
Yaroslav Kologryvov
Managing partner of Vanhealthing
验证
Eugene Nayshtetik
President of Planexta Inc.
验证
Tatiana Botsva
R&D vice president at Planexta Inc.
未验证
Maryna Moskovko
CEO of A.R.K
未验证
Valery Kanevsky
CEO of Institute of High Technologies
未验证
Yury Tymoshenko
CEO of VieGraph
未验证
Timur Shemsedinov
CEO of Interactive Cloud
验证
Sergey Stirenko
Head of the R&D department of supercomputer calcul...
未验证
Victoria Ustimenko
Chief PR Officer
验证
Inna Malyukova
Founder and managing Partner of Sikorsky Challenge
未验证

顾问

验证 50%

注意。未经证实的成员实际上可能不是团队成员

6 ICO

$36 000 000

Dr. Ben Goertzel
Advisor
未验证
Dr. Greg Colvin
Advisor
验证
Ivan Danishevsky
Advisor
验证
Irene Brinker
Advisor
未验证

VanHealthing 面试

Alexander Lobanov
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
VANHEALTHING’s mission is to reform the biotech industry and to promote humanitarian values: by opening up access to critical products and solutions and making investment more transparent. The reasoning behind this approach is simple: we understand that in the information era, personal time (which in turn is generated by personal health and psychological wellbeing) is an individual’s greatest commodity.
In healthcare, unlike in other industries, ideals attain a pragmatic aspect that directly impacts society: humanitarian values save and improve lives. We believe that in a new business paradigm, profits can be organically combined with social responsibility to create a force of positive change in the world.
Alexander Tulko
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
The Vanhealthing project is a revolutionary phenomenon that will change the biotech industry dramatically.
Yaroslav Kologryvov
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
Managing Partner
Expert in developing innovative ecosystems, science parks, hi-teck startups.
Fundraising and operating.
Eugene Nayshtetik
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
Market liquidity is a crucial component of complex biomedical development, hence the idea to provide an access to finance for long-term projects via crypto market is interesting and fresh.
Timur Shemsedinov
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I tkink following:
const emitter = (l, o) => (l = {}, o = {
on: (n, f) => (l[n] = l[n] || []).push(f),
emit: (n, ...d) => (l[n] || []).map(f => f(...d)),
once: (n, f, g) => o.on(n, g = (...a) => (f(...a), o.remove(n, g))),
remove: (n, f, e) => (e = l[n] || [], e.splice(e.indexOf(f), 1)),
clear: (n) => (n ? delete l[n] : l = {}),
count: (n) => (l[n] || []).length,
listeners: (n) => (l[n] || []).slice(),
names: () => Object.keys(l)
});
Victoria Ustimenko
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
yes, I am team member
Dr. Greg Colvin
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I provide my perspective on industry and technology to a fine team of people. This may be the future of biotech development.
Ivan Danishevsky
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
That’s working for the future! And the progress is real. Anything health and strength related excites us much.

As a tech leader in a number of companies I bring blockchain and technical expertise to all the projects in fund.

VanHealthing 最新消息

  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。